TurtleTree Labs raises $6.2m to support cell-cultured milk platform TurtleTree Labs, a biotech company building a platform to produce milk using cell-based technology, has closed an oversubscribed $6.2m pre-A funding round from new and existing global investors including Green Monday Ventures, Eat Beyond Global, KBW Ventures, and Verso Capital.
The startup - which has offices in Singapore and San Francisco - will use the funds to accelerate research and production of functional, bioactive proteins and complex sugars found in human breastmilk.
HRH Prince Khaled bin Alwaleed bin Talal Al Saud (an investor in
TurtleTree Labs via KBW Ventures), will join as an advisor to TurtleTree, which was founded in January 2019 and emerged from stealth mode at the end of 2019.
Eat Beyond or the
Company ), an investment issuer focused on the global plant-based and alternative food sector, is announcing that its portfolio company TurtleTree Labs Pte. Ltd. (
TurtleTree ) has completed an oversubscribed US$6.2 million Pre-A round from new and returning global investors.
TurtleTree has offices in both Singapore and San Francisco and is using its proprietary technology to create sustainable cell-based dairy milk and infant nutrition milk. It is focused on producing milk and also integrating the unique components of milk into products. TurtleTree is committed to creating cruelty-free, sustainable food systems. We are thrilled to be involved with TurtleTree and look forward to being involved in its continued growth and success, said Patrick Morris, CEO of Eat Beyond. There is tremendous potential in cell-based food products including meat and milk, and TurtleTree is truly one of the companies leading this charge globally.
“The vision of TurtleTree Labs is to create a truly sustainable and cruelty-free food system,” said Max Rye, co-founder and chief strategist of TurtleTree Labs. “We are grateful to have the support of leading investors from every corner of the world.”
It won the Entrepreneurship World Cup 2020, the world’s biggest start-up pitch competition in Saudi Arabia, and secured a cash prize of $500,000 in October. The EWC received entries from more than 175,000 start-ups from nearly 200 countries.
The company also announced that Prince Khaled will join TurtleTree Labs as an adviser. Other venture capital investors who participated in the pre-A funding round include Green Monday Ventures, Eat Beyond Global and Verso Capital.
KBW Ventures invests in TurtleTree Labsâ $6.2 million pre-Series A
Prince Khaled bin Alwaleed bin Talal Al Saud, CEO of KBW Ventures
UAE-based KBW Ventures, has participated in the $6.2 million pre-Series A funding round for Singapore-based TurtleTree Labs, a biotechnology company that uses technology to create real milk from animal cells.
Other investors participating in this round include Green Monday Ventures, Eat Beyond Global and Verso Capital.
TurtleTree Labs is the world s first milk company using cell cultivation to create the full nutritional content of milk using just mammary cells, with no animal needed. The end product is the same as human breast milk and cow milk and will be sold as a food product.